Use of anti-PGL-1 antibodies to monitor therapy regimes in leprosy patients (2009)
Source: Brazilian Journal of Medical and Biological Research. Unidade: FMRP
Subjects: HANSENÍASE, ANTICORPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZENHA, E. M. R. e FERREIRA, M. A. N. e FOSS, Norma Tiraboschi. Use of anti-PGL-1 antibodies to monitor therapy regimes in leprosy patients. Brazilian Journal of Medical and Biological Research, v. 42, n. 10, p. 968-972, 2009Tradução . . Disponível em: https://doi.org/10.1590/s0100-879x2009001000016. Acesso em: 17 nov. 2024.APA
Zenha, E. M. R., Ferreira, M. A. N., & Foss, N. T. (2009). Use of anti-PGL-1 antibodies to monitor therapy regimes in leprosy patients. Brazilian Journal of Medical and Biological Research, 42( 10), 968-972. doi:10.1590/s0100-879x2009001000016NLM
Zenha EMR, Ferreira MAN, Foss NT. Use of anti-PGL-1 antibodies to monitor therapy regimes in leprosy patients [Internet]. Brazilian Journal of Medical and Biological Research. 2009 ; 42( 10): 968-972.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1590/s0100-879x2009001000016Vancouver
Zenha EMR, Ferreira MAN, Foss NT. Use of anti-PGL-1 antibodies to monitor therapy regimes in leprosy patients [Internet]. Brazilian Journal of Medical and Biological Research. 2009 ; 42( 10): 968-972.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1590/s0100-879x2009001000016
